Article Details
Retrieved on: 2017-12-20 21:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>... genomic science, Freenome is currently developing noninvasive blood tests to detect early-stage cancer and make treatments more effective. In 2017, the company completed $72 million in Series A funding led by <b>Andreessen Horowitz</b> and including Google Ventures, Polaris Partners, and Founders ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here